MD

Murugan Desappan

Active Director Additional Director DIN 11394890
DIN 11394890 First appointment Nov 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Murugan Desappan

Data last updated:

Murugan Desappan is an Additional Director at Jacqs Pharma And Healthcare Private Limited (since 2025). The company operates in Paper.

DIN 11394890
Primary Designation Additional Director
Industry Paper
First Appointment 29 Nov 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director29 Nov 20252024Active

Board colleagues of Murugan Desappan

NameDINCompanyDesignation
Jacqueline Carroll10824738Jacqs Pharma And Healthcare Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Jacqs Pharma And Healthcare Private Limited
Premium access

Shareholding and investment profile for Murugan Desappan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Murugan Desappan

Murugan Desappan currently holds 1 directorship: Jacqs Pharma And Healthcare Private Limited (Additional Director, since 29 Nov 2025).

Murugan Desappan was first appointed on 29 Nov 2025 as Additional Director at Jacqs Pharma And Healthcare Private Limited.

The current boards of Murugan Desappan's companies include Jacqueline Carroll (Jacqs Pharma And Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available